MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The comp...
MiniMed SVP, General Counsel Courtney Nelson Wills resigns effective Sept. 25
MiniMed Flex™ Now Available to Medicare and Medicare Advantage Beneficiaries | MMED Stock News
MiniMed to Announce Its Fiscal Year 2027 First Quarter Financial Results | MMED Stock News
Citi Sticks to Its Buy Rating for MiniMed Group, Inc. (MMED)
Analyst Reiterates Buy on MMED, Citing Strong Diabetes Tech Pipeline and Execution, With Price Target Unchanged at $20
MiniMed Group director Scott T. Cundy files initial beneficial ownership statement